♟️ Wednesday 15 April 2026 Wed, 15 Apr 2026

Noronex completed maiden drilling programs at key uranium and copper projects while bolstering its cash position through strategic asset sales. The company also formalised a 51% stake in its Etango North uranium project and navigates a CEO transition.

Asara Resources (ASX:AS1) is pushing ahead at its Kada Gold Project in Guinea’s prolific Siguiri Basin, boasting a 923,000-ounce gold resource and launching expansive 2026 drilling campaigns aimed at significantly growing both Indicated and Inferred categories.

Noxopharm appoints its Chief Scientific Officer Dr Olivier Laczka as CEO, aiming to capitalise on recent clinical successes and expand the Sofra™ technology’s reach in autoimmune and oncology markets.

Mesoblast has acquired exclusive rights to a patented chimeric antigen receptor platform designed to enhance the targeting and potency of its mesenchymal stromal cell therapies, aiming to expand treatment options for inflammatory and autoimmune diseases.

Larvotto Resources is progressing the Hillgrove Antimony-Gold Project on time and budget, aiming for mid-2026 production amid rising strategic demand for antimony. The project benefits from grid power, ongoing drilling success, and government support for critical minerals.

Magnum Mining names Antonio Vitor Junior as Managing Director to spearhead major drilling campaigns at its Azimuth and Parker projects, aiming to convert promising early rare earth results into a formal resource.

Shine Justice reshuffles its top management as Simon Morrison steps down from Managing Director to Executive Director to spearhead international growth, particularly in its burgeoning mass torts program, while Carolyn Barker AM maintains overall CEO leadership.

AusQuest gears up for maiden drilling at two promising copper-gold prospects in Peru, aiming to build on the momentum from its Cangallo discovery. Over 8,000 metres of Reverse Circulation drilling are set to test high-priority IOCG and porphyry targets starting Q2 2026.

Nufarm reports a robust first half of FY26 with underlying EBITDA rising 17% and net debt falling by $130 million, while new CEO Rico Christensen initiates a $50 million cost savings program as part of a strategic refresh.

Evolution Mining (ASX: EVN) ended March 2026 with a net cash position of $42 million and a $1.37 billion cash balance, driven by strong cash flow from high-margin operations and on-track production.

National Storage REIT securityholders have overwhelmingly approved the Brookfield-GIC consortium's $2.86 per security cash acquisition, paving the way for a $6.7 billion transaction expected to complete in May 2026.

Aurum Resources has consolidated a 4.2 million ounce gold resource across its Boundiali and Napié projects in Côte d’Ivoire, progressing a central processing hub and expanding drilling programs as it targets development milestones in 2026.

Nufarm posted a 17% rise in underlying EBITDA for 1H FY26 and unveiled a fresh $50 million cost saving initiative under new CEO Rico Christensen, aiming to sharpen earnings quality and accelerate debt reduction.

Infini Resources is showcasing its Canadian uranium portfolio at the Ignite Investment Summit 2026, underscoring recent district-scale mineralisation and ambitious drilling campaigns planned across its Portland Creek and Athabasca margin projects.

AVITA Medical’s Cohealyx-I study interim results show a significant acceleration in skin grafting time for full-thickness wounds, reducing mean time to graft from 33.2 to 13.6 days. The ongoing trial’s promising data could reshape wound care protocols.

Forrestania Resources has revealed further high-grade niobium mineralisation from its maiden RC drilling at the Wozi Project, Malawi, validating a large near-surface system with grades up to 0.94% Nb2O5 and confirming the project's critical minerals potential.

Comvita launches a NZ$30 million renounceable Rights Offer to refinance debt and bring Southeast Asian consumer giant Fraser and Neave onboard as a strategic investor with a near 20% stake.